BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 22664238)

  • 21. Synergistic inhibition effect of tumor growth by using celecoxib in combination with oxaliplatin.
    Zhao S; Cai J; Bian H; Gui L; Zhao F
    Cancer Invest; 2009 Jul; 27(6):636-40. PubMed ID: 19387877
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Calcium-activated endoplasmic reticulum stress as a major component of tumor cell death induced by 2,5-dimethyl-celecoxib, a non-coxib analogue of celecoxib.
    Pyrko P; Kardosh A; Liu YT; Soriano N; Xiong W; Chow RH; Uddin J; Petasis NA; Mircheff AK; Farley RA; Louie SG; Chen TC; Schönthal AH
    Mol Cancer Ther; 2007 Apr; 6(4):1262-75. PubMed ID: 17431104
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synergism between the anticancer actions of 2-methoxyestradiol and microtubule-disrupting agents in human breast cancer.
    Han GZ; Liu ZJ; Shimoi K; Zhu BT
    Cancer Res; 2005 Jan; 65(2):387-93. PubMed ID: 15695378
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synergistic interactions of chemotherapeutic drugs and tumor necrosis factor-related apoptosis-inducing ligand/Apo-2 ligand on apoptosis and on regression of breast carcinoma in vivo.
    Singh TR; Shankar S; Chen X; Asim M; Srivastava RK
    Cancer Res; 2003 Sep; 63(17):5390-400. PubMed ID: 14500373
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibition of autophagy and induction of breast cancer cell death by mefloquine, an antimalarial agent.
    Sharma N; Thomas S; Golden EB; Hofman FM; Chen TC; Petasis NA; Schönthal AH; Louie SG
    Cancer Lett; 2012 Dec; 326(2):143-54. PubMed ID: 22863539
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Metformin and the mTOR inhibitor everolimus (RAD001) sensitize breast cancer cells to the cytotoxic effect of chemotherapeutic drugs in vitro.
    Liu H; Scholz C; Zang C; Schefe JH; Habbel P; Regierer AC; Schulz CO; Possinger K; Eucker J
    Anticancer Res; 2012 May; 32(5):1627-37. PubMed ID: 22593441
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Loss of tuberous sclerosis complex 2 sensitizes tumors to nelfinavir-bortezomib therapy to intensify endoplasmic reticulum stress-induced cell death.
    Johnson CE; Dunlop EA; Seifan S; McCann HD; Hay T; Parfitt GJ; Jones AT; Giles PJ; Shen MH; Sampson JR; Errington RJ; Davies DM; Tee AR
    Oncogene; 2018 Nov; 37(45):5913-5925. PubMed ID: 29980790
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Aspirin sensitizes cancer cells to TRAIL-induced apoptosis by reducing survivin levels.
    Lu M; Strohecker A; Chen F; Kwan T; Bosman J; Jordan VC; Cryns VL
    Clin Cancer Res; 2008 May; 14(10):3168-76. PubMed ID: 18483385
    [TBL] [Abstract][Full Text] [Related]  

  • 29. γ-Tocotrienol-induced endoplasmic reticulum stress and autophagy act concurrently to promote breast cancer cell death.
    Tiwari RV; Parajuli P; Sylvester PW
    Biochem Cell Biol; 2015 Aug; 93(4):306-20. PubMed ID: 25844964
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Acriflavine enhances radiosensitivity of colon cancer cells through endoplasmic reticulum stress-mediated apoptosis.
    Lim MJ; Ahn JY; Han Y; Yu CH; Kim MH; Lee SL; Lim DS; Song JY
    Int J Biochem Cell Biol; 2012 Aug; 44(8):1214-22. PubMed ID: 22564437
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interaction of celecoxib with different anti-cancer drugs is antagonistic in breast but not in other cancer cells.
    El-Awady RA; Saleh EM; Ezz M; Elsayed AM
    Toxicol Appl Pharmacol; 2011 Sep; 255(3):271-86. PubMed ID: 21763710
    [TBL] [Abstract][Full Text] [Related]  

  • 32. COX-2 independent induction of cell cycle arrest and apoptosis in colon cancer cells by the selective COX-2 inhibitor celecoxib.
    Grösch S; Tegeder I; Niederberger E; Bräutigam L; Geisslinger G
    FASEB J; 2001 Dec; 15(14):2742-4. PubMed ID: 11606477
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition of angiotensin II activity enhanced the antitumor effect of cyclooxygenase-2 inhibitors via insulin-like growth factor I receptor pathway.
    Yasumaru M; Tsuji S; Tsujii M; Irie T; Komori M; Kimura A; Nishida T; Kakiuchi Y; Kawai N; Murata H; Horimoto M; Sasaki Y; Hayashi N; Kawano S; Hori M
    Cancer Res; 2003 Oct; 63(20):6726-34. PubMed ID: 14583467
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Endoplasmic reticulum stress and cell death in mTORC1-overactive cells is induced by nelfinavir and enhanced by chloroquine.
    Johnson CE; Hunt DK; Wiltshire M; Herbert TP; Sampson JR; Errington RJ; Davies DM; Tee AR
    Mol Oncol; 2015 Mar; 9(3):675-88. PubMed ID: 25498902
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibiting autophagy with chloroquine enhances the anti-tumor effect of high-LET carbon ions via ER stress-related apoptosis.
    Zheng X; Jin X; Li F; Liu X; Liu Y; Ye F; Li P; Zhao T; Li Q
    Med Oncol; 2017 Feb; 34(2):25. PubMed ID: 28070729
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Autophagy activation in hepatocellular carcinoma contributes to the tolerance of oxaliplatin via reactive oxygen species modulation.
    Ding ZB; Hui B; Shi YH; Zhou J; Peng YF; Gu CY; Yang H; Shi GM; Ke AW; Wang XY; Song K; Dai Z; Shen YH; Fan J
    Clin Cancer Res; 2011 Oct; 17(19):6229-38. PubMed ID: 21825039
    [TBL] [Abstract][Full Text] [Related]  

  • 37. IGFBP7 reduces breast tumor growth by induction of senescence and apoptosis pathways.
    Benatar T; Yang W; Amemiya Y; Evdokimova V; Kahn H; Holloway C; Seth A
    Breast Cancer Res Treat; 2012 Jun; 133(2):563-73. PubMed ID: 21997538
    [TBL] [Abstract][Full Text] [Related]  

  • 38. AEE788 potentiates celecoxib-induced growth inhibition and apoptosis in human colon cancer cells.
    Venkatesan P; Bhutia SK; Singh AK; Das SK; Dash R; Chaudhury K; Sarkar D; Fisher PB; Mandal M
    Life Sci; 2012 Oct; 91(15-16):789-99. PubMed ID: 22922496
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Simultaneous activation and inhibition of autophagy sensitizes cancer cells to chemotherapy.
    Chi KH; Wang YS; Huang YC; Chiang HC; Chi MS; Chi CH; Wang HE; Kao SJ
    Oncotarget; 2016 Sep; 7(36):58075-58088. PubMed ID: 27486756
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Simultaneous inhibition of deubiquitinating enzymes (DUBs) and autophagy synergistically kills breast cancer cells.
    Vogel RI; Coughlin K; Scotti A; Iizuka Y; Anchoori R; Roden RB; Marastoni M; Bazzaro M
    Oncotarget; 2015 Feb; 6(6):4159-70. PubMed ID: 25784654
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.